Comment on "Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects"

J Immunol. 2011 Jan 15;186(2):647; author reply 648. doi: 10.4049/jimmunol.1090123.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Calcitriol / blood
  • Calcitriol / deficiency
  • Calcitriol / therapeutic use*
  • Female
  • Humans
  • Immunologic Factors / blood
  • Immunologic Factors / deficiency
  • Immunologic Factors / therapeutic use*
  • Male
  • Multiple Sclerosis, Relapsing-Remitting / blood
  • Multiple Sclerosis, Relapsing-Remitting / immunology*
  • Multiple Sclerosis, Relapsing-Remitting / physiopathology*
  • Sex Characteristics*
  • Vitamin D Deficiency / drug therapy
  • Vitamin D Deficiency / immunology*
  • Vitamin D Deficiency / physiopathology*

Substances

  • Immunologic Factors
  • Calcitriol